http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25669569

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't|Review
issn 1868-7075
1868-7083
issueIdentifier 1
pageRange 71-
publicationName Clinical Epigenetics
startingPage 71
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_bf9c8e5c69ff222e3ee2ff0fc4d2b289
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6ace0abd6c412d4ad70ce6dc10cfa0f2
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_744515442891f0f707eb49116387a394
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e63ea4066d6b81e9c54b2f8ecca0c14f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_92b7f4b45fe4b2935b4ba767de9da6a7
bibliographicCitation Diesch J, Zwick A, Garz A, Palau A, Buschbeck M, Götze KS. A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers. Clinical Epigenetics. 2016 Jun 21;8(1):71. doi: 10.1186/s13148-016-0237-y.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a34dc6b3a1b7f69e37ad5789db61f23
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c9d7853ec5ad1f7a91be944c2d2a7d16
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3218-4567
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5e6383d2604434c5e42e572e0eb9185
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee16dd20b9a96a129f725b0870b6c105
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4667-3468
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b231696fb6520f1da4c36a03672357ce
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab523f2680432acc04307f1a9d89d66e
date 2016-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1186/s13148-016-0237-y
https://pubmed.ncbi.nlm.nih.gov/PMC4915187
https://pubmed.ncbi.nlm.nih.gov/27330573
isPartOf https://portal.issn.org/resource/ISSN/1868-7075
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/38673
https://portal.issn.org/resource/ISSN/1868-7083
language English
source https://scigraph.springernature.com/
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers
discusses http://id.nlm.nih.gov/mesh/M0062824
http://id.nlm.nih.gov/mesh/M0001471
http://id.nlm.nih.gov/mesh/M0002060
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9444
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9731
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10364
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8560
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID451668

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1788
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1789

Total number of triples: 44.